BridgeMD
Tests treatment safety and results for Lateral Epicondylitis (Tennis Elbow)
Official title Comparison of the Effectiveness of Mulligan Mobilization and Myofascial Release Technique in Patients With Lateral Epicondylitis
ClinicalTrials.gov ID: NCT06965985
What this study is testing
- What it's testing
- Lateral epicondylitis (LE), recognized as one of the most prevalent causes of elbow pain, has an estimated incidence ranging from 1% to 3%. It most commonly presents in individuals between the ages of 40 and 50 and tends to affect the dominant limb more frequently.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Aged between 18 and 65 years
- Diagnosed with unilateral lateral epicondylitis (LE)
You likely can't join if
- Younger than 18 or older than 65 years
- Communication difficulties
- History of injection, surgery, or physical therapy in the elbow region within the past 6 months
- Pain originating from the cervical spine (e.g., radiculopathy, spinal stenosis), shoulder problems, or other elbow pathologies unrelated to LE
- History of elbow osteoarthritis or previous elbow fracture
- History of polyneuropathy
See the full eligibility criteria
- Aged between 18 and 65 years
- Diagnosed with unilateral lateral epicondylitis (LE)
- Younger than 18 or older than 65 years
- Communication difficulties
- History of injection, surgery, or physical therapy in the elbow region within the past 6 months
- Pain originating from the cervical spine (e.g., radiculopathy, spinal stenosis), shoulder problems, or other elbow pathologies unrelated to LE
- History of elbow osteoarthritis or previous elbow fracture
- History of polyneuropathy
- Uncontrolled systemic diseases (e.g., cardiovascular, pulmonary, hepatic, renal, hematologic disorders)
- Uncontrolled systemic endocrine disorders (e.g., diabetes mellitus, hyperthyroidism)
- History of major psychiatric disorders
- History of rheumatic diseases such as fibromyalgia, polymyalgia rheumatica, ankylosing spondylitis, or rheumatoid arthritis
- Presence of bleeding disorders or use of anticoagulant medications
- Neurological deficits
- Posterior interosseous nerve (PIN) syndrome
- Current or past use of wrist resting splints or elbow braces
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Selçuklu, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Selçuklu, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.